第三条 本办法所称对外担保是指公司为他人提供的担保，包括公司 对控股子公司的担保。公司控股子公司为公司合并报表范围内的法人或者 其他组织提供担保的，公司应当在控股子公司履行审议程序后及时披露， 按照《上海证券交易所股票上市规则》应当提交公司股东会审议的担保事 项除外。公司控股子公司为公司合并报表范围以外的主体提供担保的，视 同公司提供担保，应当执行本办法的审议程序及对外信息披露要求。 第四条 公司及控股子公司提供反担保应当比照担保的相关规定执 行，以其提供的反担保金额为标准履行相应审议程序和信息披露义务，但 1 公司及控股子公司为以自身债务为基础的担保提供反担保的除外。 第五条 公司对外担保实行统一管理，非经公司董事会或股东会批 准，任何人无权以公司名义签署对外担保的合同、协议或其他类似的法律 文件。 中泰证券股份有限公司对外担保管理办法 （2025 年 10 月修订） 第一章 总则 第一条 为规范中泰证券股份有限公司（以下简称"公司"）对外担保 行为，有效控制公司对外担保风险，保护公司财务安全和投资者的合法权 益，根据《中华人民共和国民法典》《中华人民共和国公司法》《中华人民 共和国证券法》《上市公司监管指 ...

中泰证券股份有限公司募集资金管理办法 （2025 年 10 月修订） 第一章 总则 第一条 为规范中泰证券股份有限公司（以下简称"公司"）募集资 金的使用与管理，提高募集资金使用效益，保护投资者的合法权益，根据 《中华人民共和国公司法》《中华人民共和国证券法》《首次公开发行股 票注册管理办法》《上市公司证券发行注册管理办法》《上市公司募集资 金监管规则》《上海证券交易所股票上市规则》《上海证券交易所上市公 司自律监管指引第 1 号——规范运作》等法律法规、规范性文件及《公司 章程》的有关规定，结合公司实际情况，制定本办法。 第二条 本办法所称募集资金是指公司通过发行股票或者其他具有 股权性质的证券，向投资者募集并用于特定用途的资金，不包括公司为实 施股权激励计划募集的资金。本办法所称超募资金是指实际募集资金净额 超过计划募集资金金额的部分。 第三条 公司董事会应持续关注募集资金存放、管理和使用情况，有 效防范投资风险，提高募集资金使用效益。公司的董事和高级管理人员应 当勤勉尽责，确保公司募集资金安全，不得操控公司擅自或者变相改变募 集资金用途。 第四条 公司在其他交易场所发行证券有相关规定的，遵从相关规 定。 ...

公司董事会应当切实履行职责，认真、按时组织股东会。公司全 体董事应当勤勉尽责，确保股东会正常召开和依法行使职权。 中泰证券股份有限公司股东会议事规则 （2025 年 10 月修订） 第一章 总则 第一条 为规范中泰证券股份有限公司（以下简称"公司"）行 为，保证股东会依法行使职权，完善公司治理结构，根据《中华人民 共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》 （以下简称《证券法》）、《上市公司股东会规则》《上海证券交易 所股票上市规则》及其他相关法律、行政法规和《公司章程》的规定， 制定本规则。 第二条 公司股东会的召集、提案、通知、召开等事项适用本规 则。 第三条 公司应当严格按照法律、行政法规、本规则及公司章程 的相关规定召开股东会，保证股东能够依法行使权利。 （二）公司未弥补的亏损达股本总额的三分之一； （三）单独或者合计持有公司百分之十以上股份的股东书面请求 时； （四）董事会认为必要时； （五）董事会审计委员会（以下简称"审计委员会"）提议召开 时； （六）法律、行政法规、部门规章或者公司章程规定的其他情形。 前述第（三）项持股股数按股东提出书面要求日计算。 第四条 股东会应当在《 ...

Core Viewpoint - The performance of A-share listed securities firms has generally improved in the first three quarters of the year, driven by the rise in the A-share market, particularly in brokerage and proprietary trading businesses, although significant disparities in performance among firms have emerged [1][2][3]. Group 1: Overall Performance - All 42 listed securities firms reported year-on-year revenue growth in the first three quarters, except for Western Securities, which saw a slight decline [1][2]. - The leading firm, CITIC Securities, achieved a total revenue of 55.815 billion yuan, a year-on-year increase of 32.7%, with net profit rising by 37.86% to 23.159 billion yuan [2]. - Notable performers include Guotai Junan and Guolian Minsheng, with revenue growth of 101.6% and 201.17%, respectively [2][3]. Group 2: Business Segmentation - Brokerage and proprietary trading businesses have been the main drivers of revenue growth, with all firms reporting positive growth in brokerage income, and 38 firms seeing increases of over 50% [6][8]. - Guolian Minsheng's brokerage income surged by 293%, while Guotai Junan's increased by 143% [6]. - Proprietary trading also performed well, with Longjiang Securities reporting a 290% increase in proprietary income [6]. Group 3: Performance Disparities - Despite overall growth, some firms like Western Securities experienced revenue declines, although their net profit increased significantly due to improved efficiency and cost management [3][5]. - The disparity in performance is evident, with some firms' proprietary trading income declining, while others saw substantial increases [7][8]. - The investment banking sector has faced challenges, with several firms reporting declines in income, attributed to a shift of companies opting for listings in Hong Kong instead of A-shares [8]. Group 4: Market Sentiment and Stock Performance - The stock prices of securities firms have shown significant divergence from their performance, with a notable drop following a market downturn despite a cumulative increase of over 31% since April [9][11]. - Analysts suggest that the traditional logic of "bull markets favoring securities firms" is changing, indicating a more structural rather than broad-based market recovery [13].

Core Insights - The medical ETF (159865) has seen a net inflow of 9 million units, indicating strong capital interest in medical assets [1] - The "14th Five-Year Plan" emphasizes support for innovation in medical devices, aiming to make high-end medical equipment a growth driver for the economy [1] - The demand in niche areas such as emergency equipment and in-vitro diagnostics is expected to be released [1] - The innovative pharmaceuticals and medical devices sector is identified as the most promising growth area within the healthcare sector, with current adjustments primarily influenced by market sentiment [1] - As third-quarter reports are being disclosed, earnings certainty is becoming a key focus in the short term [1] - It is recommended to leverage policy benefits and industrial upgrade paths to seize opportunities in innovation-driven enterprises [1] - The medical ETF (159828) tracks the CSI Medical Index (399989), which selects listed companies in the medical and pharmaceutical retail sectors from the Shanghai and Shenzhen markets [1] - The index primarily covers areas such as medical devices, medical services, and medical R&D outsourcing, reflecting the overall performance of related listed companies [1] - The constituent stocks of the index tend to be small to mid-cap, characterized by high growth potential and volatility [1]

Group 1 - The core point of the news is that Sanhuan Group's stock price dropped by 5.07% to 49.26 CNY per share, with a trading volume of 1.192 billion CNY and a turnover rate of 1.27%, resulting in a total market capitalization of 94.407 billion CNY [1] - Sanhuan Group, established on December 10, 1992, and listed on December 3, 2014, is located in Chaozhou, Guangdong Province, and specializes in the research, production, and sales of electronic components and their basic materials [1] - The main business revenue composition of Sanhuan Group is 98.84% from electronic and communication components and materials, with other supplementary sources contributing 1.16% [1] Group 2 - From the perspective of fund holdings, one fund under Zhongtai Securities Asset Management has a significant position in Sanhuan Group, specifically the Zhongtai Xingrui Prosperity Growth Mixed A fund, which held 40,700 shares, accounting for 3% of the fund's net value, ranking as the eighth largest holding [2] - The Zhongtai Xingrui Prosperity Growth Mixed A fund was established on July 18, 2023, with a latest scale of 30.3584 million CNY, achieving a year-to-date return of 37.72% and a one-year return of 31.27% [2] - The fund manager, Gao Lanjun, has a tenure of 6 years and 135 days, with the fund's total asset scale at 62.8714 million CNY, and the best and worst returns during his tenure being 126.62% and 18.32%, respectively [2]

Core Insights - In the period from January to October 2025, a total of 87 new companies were listed on the A-share market, representing an 8.75% increase compared to the same period last year, which had 80 new listings [1] - The total net fundraising amount for these 87 new listings reached 833.81 billion yuan, marking a significant 77.02% increase from 471.02 billion yuan in the same period last year [1] Underwriting Institutions Performance Ranking - A total of 29 underwriting institutions participated in the IPOs of these 87 new companies, with a total of 88 deals completed [2] - The top five underwriting institutions by number of deals are: - 1st: Guotai Junan with 11 deals - 2nd: CITIC Securities with 10 deals - 3rd: Huatai United with 8 deals - 4th: CITIC Jianzhong with 7 deals - 5th: China Merchants Securities with 5 deals [2][3] Law Firms Performance Ranking - In the same period, 28 law firms provided legal services for the IPOs of the 87 new companies [6] - The top five law firms by number of deals are: - 1st: Shanghai Jintiancheng with 13 deals - 2nd: Beijing Deheng and Beijing Zhonglun, both with 7 deals - 4th: Beijing Guofeng with 6 deals - 5th: Shanghai Tongli with 5 deals [6][7] Accounting Firms Performance Ranking - A total of 16 accounting firms provided auditing services for the 87 new listings [9] - The top five accounting firms by number of deals are: - 1st: Rongcheng with 20 deals - 2nd: Tianjian with 16 deals - 3rd: Lixin and Zhonghui, both with 11 deals - 5th: Ernst & Young Hua Ming, KPMG Huazhen, and Zhongshen Zhonghuan, each with 4 deals [9][10]

Core Viewpoint - The report from Zhongtai Securities indicates that while the technology sector has high internal competition among sub-sectors, the overall technology style is not crowded. [1] Summary by Categories Technology Sector - 59.5% of the tracked technology sub-sectors have a trading volume that exceeds the 75% level of the technology sector over the past three years [1] - The trading volume of the major technology category currently stands at the 50th percentile of the past three years in relation to the entire A-share market [1] Investment Recommendations - Focus on technology sub-sectors with less internal trading competition, such as Hong Kong internet and consumer electronics [1] - Consider global pricing resources that benefit from Federal Reserve interest rate cuts and overseas fiscal expansion, such as gold and copper [1] - Pay attention to manufacturing sectors related to overseas demand [1]

Core Insights - The market odds indicator is currently at a relatively high level under a "structural bull" scenario [1] - The A-share market's securitization rate and median valuation are comparable to the structural bull levels at the end of 2021, with historical exceedance only during the comprehensive bull markets of 2009 and 2015 [1] - The Shanghai Composite Index and CSI 300's equity risk premium (ERP) is below the previous two market peaks, situated at the lower end of the rolling three-year average plus two standard deviations [1] - Overall, under the "structural bull" scenario, the market's odds space is relatively limited, and historical experience suggests that a transition to a comprehensive bull market would require a significant improvement in macro expectations or further liquidity expansion [1]

中泰证券研报称，随着10月30日中美元首会晤临近，市场市场情绪有望进一步回暖，预计将开启新一轮 行情。短期配置方向上，可重点关注三条主线：一是AI应用板块，尤其是机器人、端侧AI及恒生科技 指数相关标的；二是"反内卷"主题下的创业板细分产业，如多晶硅、光伏组件等具备高景气预期的制造 链环节；三是券商板块。 ...